Document Detail


IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice.
MedLine Citation:
PMID:  20014946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chemotherapeutic agents produce persistent difficulties in memory through an unknown mechanism. We tested the hypothesis that chemotherapeutic agents readily able to cross the blood-brain barrier (cyclophosphamide and fluorouracil), as opposed to those not known to readily cross the barrier (paclitaxel and doxorubicin), reduce neural cell proliferation following chemotherapy. We found that 5-bromo-2-deoxyuridine labeling following chemotherapy given to C57BL/6 mice revealed a similar reduction in neural cell proliferation in the dentate gyrus for all four agents. Insulin-like growth factor 1, a molecule implicated in promoting neurogenesis, counteracted the effects of high doses of chemotherapy on neural cell proliferation.
Authors:
Michelle C Janelsins; Joseph A Roscoe; Michel J Berg; Bryan D Thompson; Mark J Gallagher; Gary R Morrow; Charles E Heckler; Pascal Jean-Pierre; Lisa A Opanashuk; Robert A Gross
Related Documents :
1976556 - Transiently catecholaminergic (tc) cells in the bowel of the fetal rat: precursors of n...
15312996 - Starch acetate microparticles for drug delivery into retinal pigment epithelium-in vitr...
20818256 - Hes1 is required for the development of craniofacial structures derived from ectomesenc...
10906446 - Role of the extracellular matrix during neural crest cell migration.
24759836 - Induction of pluripotency in human somatic cells via a transient state resembling primi...
23315586 - Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Cancer investigation     Volume:  28     ISSN:  1532-4192     ISO Abbreviation:  Cancer Invest.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-10     Completed Date:  2010-05-14     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  8307154     Medline TA:  Cancer Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  544-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / metabolism,  toxicity*
Blood-Brain Barrier*
Bromodeoxyuridine / metabolism
Cell Proliferation / drug effects
Cyclophosphamide / toxicity
Dentate Gyrus / drug effects*
Doxorubicin / toxicity
Fluorouracil / toxicity
Humans
Insulin-Like Growth Factor I / pharmacology*
Mice
Mice, Inbred C57BL
Neurogenesis / drug effects
Neurons / drug effects
Paclitaxel / toxicity
Weight Loss
Grant Support
ID/Acronym/Agency:
R25 CA102618/CA/NCI NIH HHS; R25 CA102618-06A1/CA/NCI NIH HHS; R25CA01618/CA/NCI NIH HHS; U10 CA037420/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 33069-62-4/Paclitaxel; 67763-96-6/Insulin-Like Growth Factor I; 80168379AG/Doxorubicin; 8N3DW7272P/Cyclophosphamide; G34N38R2N1/Bromodeoxyuridine; U3P01618RT/Fluorouracil
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correlation Between Argyrophilic Nucleolar Organizer Region Staining and Brain Tumor Classification ...
Next Document:  Expression and Mutation Analysis of Her2 in Head and Neck Squamous Cell Carcinoma.